AAAAAA
Results: 26-50/71
Authors:
FRISKE M
SCHRAMM W
LANDGRAF R
RENNER R
GOTTSMANN M
KOCH H
RUHLAND B
STANDL E
PIWERNETZ K
Citation: M. Friske et al., THE SPECIALITY COMMISSION DIABETES - A NONPROFIT ORGANIZATION FOR IMPROVEMENT OF DIABETES CARE IN BAVARIA, GERMANY, Diabetologia, 40, 1997, pp. 2639-2639
Authors:
FUCHTENBUSCH M
FERBER K
STANDL E
ZIEGLER AG
Citation: M. Fuchtenbusch et al., PREDICTION OF TYPE-1 DIABETES POSTPARTUM IN PATIENTS WITH GESTATIONALDIABETES-MELLITUS BY COMBINED ISLET-CELL AUTOANTIBODY SCREENING - A PROSPECTIVE MULTICENTER STUDY, Diabetes, 46(9), 1997, pp. 1459-1467
Authors:
SCHNELL O
EISFELDER B
STANDL E
ZIEGLER AG
Citation: O. Schnell et al., HIGH-DOSE INTRAVENOUS INSULIN INFUSION VERSUS INTENSIVE INSULIN-TREATMENT IN NEWLY-DIAGNOSED IDDM, Diabetes, 46(10), 1997, pp. 1607-1611
Authors:
FUCHTENBUSCH M
FERBER K
STANDL E
ZIEGLER AG
Citation: M. Fuchtenbusch et al., PREDICTION OF TYPE-I DIABETES POSTPARTUM IN PATIENTS WITH GESTATIONALDIABETES-MELLITUS BY COMBINED ISLET-CELL AUTOANTIBODY SCREENING, Diabetes, 46, 1997, pp. 56-56
Authors:
MUHR D
MOLLENHAUER U
HASLBECK M
STANDL E
ZIEGLER AG
SCHNELL O
Citation: D. Muhr et al., AUTOANTIBODIES TO ANTIGENS EXPRESSED IN NERVOUS TISSUES ARE NOT ASSOCIATED WITH CARDIAC AUTONOMIC NEUROPATHY IN IDDM, Diabetes, 46, 1997, pp. 491-491
Authors:
DITTLER J
SCHILLER M
MOLLENHAUER U
SEIDEL D
STANDL E
ZIEGLER AG
Citation: J. Dittler et al., DEVELOPMENT OF A COMBINED GADIA2-ANTIBODY TEST SYSTEM IN VENOUS AND CAPILLARY BLOOD FOR SCREENING AND IMPROVED PREDICTION OF IDDM, Diabetes, 46, 1997, pp. 756-756
Authors:
STANDL E
BAUMGARTL HJ
FUECHTENBUSCH M
STEMPLINGER J
Citation: E. Standl et al., EFFECT OF ACARBOSE ON ADDITIONAL INSULIN THERAPY OF TYPE-II DIABETICSWITH LATE FAILURE OF SULFONYLUREA THERAPY, Diabetes, 46, 1997, pp. 1127-1127
Authors:
SCHNELL O
STENNER T
STANDL E
HASLBECK M
Citation: O. Schnell et al., VALUE OF RATE-CORRECTED QT INTERVAL FOR T HE DIAGNOSIS OF CARDIAC AUTONOMIC NEUROPATHY IN LONG-STANDING TYPE-1 DIABETES-MELLITUS, Deutsche Medizinische Wochenschrift, 121(25-26), 1996, pp. 819-822
Authors:
MAYRHOFER M
RABIN DU
MESSENGER L
STANDL E
ZIEGLER AG
Citation: M. Mayrhofer et al., VALUE OF ICA512 ANTIBODIES FOR PREDICTION AND DIAGNOSIS OF TYPE-1 DIABETES, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 104(3), 1996, pp. 228-234
Authors:
WICKLMAYR M
RETT K
STANDL E
Citation: M. Wicklmayr et al., SIGNIFICANT HYPERINSULINEMIA IN NEW-ONSET TYPE-2 DIABETES, Medizinische Klinik, 91(4), 1996, pp. 189-192
Authors:
EWING D
STANDL E
JANKA HU",GELIAN,"LEBOVITZ H
Citation: D. Ewing et al., DIABETIC AUTONOMIC NEUROPATHY AND THE HEART, Diabetes research and clinical practice, 30, 1996, pp. 145-146
Authors:
MACK W
STANDL E",GOERPE,HANEFELD,"JANKA HU
LEBOVITZ H
GOTO Y
Citation: W. Mack et al., EFFICACY OF INTERVENTIONS DESIGNED TO INHIBIT THE PROGRESSION OF CORONARY ATHEROSCLEROSIS, Diabetes research and clinical practice, 30, 1996, pp. 146-149
Authors:
YAZAKI Y
LEBOVITZ H
GAY S
STANDL E
CHIASSON JL
Citation: Y. Yazaki et al., ANGIOTENSIN-II MEDIATES MECHANICAL STRESS-INDUCED CARDIAC-HYPERTROPHY, Diabetes research and clinical practice, 30, 1996, pp. 152-154
Authors:
STANDL E
Citation: E. Standl, METABOLIC SYNDROME AND FATAL QUARTET, Der Internist, 37(7), 1996, pp. 698-704
Authors:
SCHNELL O
MUHR D
DRESEL S
TATSCH K
ZIEGLER AG
HASLBECK M
STANDL E
Citation: O. Schnell et al., AUTOANTIBODIES AGAINST SYMPATHETIC-GANGLIA AND EVIDENCE OF CARDIAC SYMPATHETIC DYSINNERVATION IN NEWLY-DIAGNOSED AND LONG-TERM IDDM PATIENTS, Diabetologia, 39(8), 1996, pp. 970-975
Authors:
STANDL E
BALLETSHOFER B
DAHL B
WEICHENHAIN B
STIEGLER H
HORMANN A
HOLLE R
Citation: E. Standl et al., PREDICTORS OF 10-YEAR MACROVASCULAR AND OVERALL MORTALITY IN PATIENTSWITH NIDDM - THE MUNICH GENERAL-PRACTITIONER PROJECT, Diabetologia, 39(12), 1996, pp. 1540-1545
Authors:
FERBER K
FUCHTENBUSCH M
HUMMEL M
STANDL E
ALBERT E
ZIEGLER AG
Citation: K. Ferber et al., COMBINED ISLET-CELL ANTIBODY TESTING IN PATIENTS WITH GESTATIONAL DIABETES - A PROSPECTIVE FOLLOW-UP-STUDY, Diabetologia, 39, 1996, pp. 61-61
Authors:
EISFELDER B
ZIEGLER AG
STANDL E
SCHNELL O
Citation: B. Eisfelder et al., OP-32 - INSULIN THERAPY - IDDM - HIGH-DOSE INTRAVENOUS INSULIN INFUSION IN NEWLY-DIAGNOSED IDDM - EFFECTS ON BETA-CELL FUNCTION, Diabetologia, 39, 1996, pp. 185-185
Authors:
BIERMANN E
HEINLEIN W
KOTHNY T
STANDL E
Citation: E. Biermann et al., THERAPY-RELATED AND EDUCATION-RELATED DIFFERENCES BETWEEN PATIENTS WITH IDDM ONE-YEAR AFTER A STRUCTURED EDUCATION IS ICT, Diabetologia, 39, 1996, pp. 755-755
Authors:
KROB G
SCHNELL O
RUF A
STANDL E
HASLBECK M
Citation: G. Krob et al., THE SIGNIFICANCE OF THE DURATION OF CLINICAL SYMPTOMS FOR CARDIAC AUTONOMIC AND PERIPHERAL SENSORY NEUROPATHY IN NEWLY-DIAGNOSED IDDM, Diabetologia, 39, 1996, pp. 980-980
Authors:
BAUMGARTL HJ
STANDL E
VLASSARA H
BUCALA R
Citation: Hj. Baumgartl et al., INCREASE IN SERUM AGES (ADVANCED GLYCOSYLATION END-PRODUCTS) IN IDDM PATIENTS WHO SMOKE, Diabetologia, 39, 1996, pp. 1111-1111
Authors:
SCHNELL O
MUHR D
WEISS M
DRESEL S
HASLBECK M
STANDL E
Citation: O. Schnell et al., REDUCED MYOCARDIAL I-123 METAIODOBENZYLGUANIDINE UPTAKE IN NEWLY-DIAGNOSED IDDM PATIENTS, Diabetes, 45(6), 1996, pp. 801-805
Authors:
SCHERNTHANER G
FEIG P
HANEFELD M
PETZINNA D
RAPTIS S
RYBKA J
STANDL E
Citation: G. Schernthaner et al., COMPARISON OF MIGLITOL AND METFORMIN IN NIDDM PATIENTS NOT RESPONDINGSUFFICIENTLY TO SULFONYLUREA, Diabetes, 45, 1996, pp. 445-445
Authors:
SCHERNTAHNER G
FEIG P
HANEFELD M
PETZINNA D
RAPTIS S
RYBKA J
STANDL E
Citation: G. Scherntahner et al., COMPARISON OF MIGLITOL AND METFORMIN IN NIDDM NOT SUFFICIENTLY RESPONDING TO SULFONYLUREAS, Diabetes, 45, 1996, pp. 746-746
Authors:
RETT K
WICKLMAYR M
STANDL E
Citation: K. Rett et al., MANAGEMENT OF THE PATIENT WITH TYPE-2 DIABETES - WHAT IS NEW, Nephrology, dialysis, transplantation, 10(10), 1995, pp. 1787-1788